Rigel Pharmaceuticals Q4 Adj. EPS $1.12 Misses $1.25 Estimate, Sales $69.802M Beat $68.701M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsEarnings MissesNews
Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $1.12 per share which missed the analyst consensus estimate of $1.25 by 10.18 percent. This is a 40 percent increase over earnings of $0.80 per share
Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $1.12 per share which missed the analyst consensus estimate of $1.25 by 10.18 percent. This is a 40 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $69.802 million which beat the analyst consensus estimate of $68.701 million by 1.60 percent. This is a 21.19 percent increase over sales of $57.596 million the same period last year.